ARCHIVES

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 37 No. 30 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

Nevins: Duke Administration Did a “Very Good Job” Of Handling The Crisis

April 1, 2011

Virus Program Report On Scientific Activities

August 8, 1975